Whitish Patch over Soft Palate: A Case Report of Incidental Finding of Basaloid Squamous Cell Carcinoma
DOI:
https://doi.org/10.32734/sumej.v6i3.13272Keywords:
basaloid squamous cell carcinoma, conventional squamous cell carcinoma, immunohistochemistry, oropharyngeal carcinoma, soft palate, squamous cell carcinomaAbstract
Background: Whitish lesion over the oropharyngeal mucosal lesion is traditionally attributed to benign lesions such as leukoplakia, oral candidiasis or lichen planus, which can be diagnosed through histopathological examination. Yet, performing a biopsy is prudent in all cases of persistent whitish lesions to rule out a more sinister pathology such as malignancy. Objective: To report an incidental finding of a whitish lesion in the soft palate of a gentleman who presented with otalgia and otorrhea, which turned out to be basaloid squamous cell carcinoma (BSCC). Methods: We performed a thorough examination in a patient presenting with ear symptoms, during which a whitish palatal lesion was incidentally discovered. Histopathological examination was carried out to confirm the diagnosis. Results: Histopathological analysis revealed that the whitish palatal lesion was basaloid squamous cell carcinoma (BSCC). Conclusion: Thorough, meticulous, and complete Ear, Nose and Throat examinations in all patients are crucial, as they enable early diagnosis of sinister pathologies, such as BSCC, even when presenting symptoms seem unrelated.
Downloads
References
[1] Ramakrishnan S. Basaloid squamous cell carcinoma of oral cavity: report of two cases. 2012 Jan.
[2] Xie S, Bredell M, Yang H, Shen S, Yang H. Basaloid squamous cell carcinoma of the maxillary gingiva: a case report and review of the literature. Oncol Lett. 2014;8(3):1287-1290. Available from: https://doi.org/10.3892/ol.2014.2318.
[3] Heera R, Ayswarya T, Padmakumar SK, Ismayil P. Basaloid squamous cell carcinoma of oral cavity: report of two cases. J Oral Maxillofac Pathol. 2016;20(1):29-32. Available from: https://doi.org/10.4103/0973-029X.190964.
[4] Jain N, Raut T, Keshwar S, Shrestha A, Jaisani MR, Paudel D. Histopathological characterization of a series of oral basaloid squamous cell carcinoma: case series. Case Rep Pathol. 2023;2023:1-5.
[5] Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17(11):1158-1166.
[6] Bhanja KC, Mallick SK. Cutaneous basaloid squamous cell carcinoma of the face, a rare variant: a case report. Int J Case Rep Images. 2011;3(1):20-23. Available from: https://doi.org/10.5348/ijcri.
[7] Linton OR, Moore MG, Brigance JS, Gordon CA, Summerlin D, McDonald MW. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2013;139(12):1306-1311. Available from: https://doi.org/10.1001/jamaoto.2013.5308.
[8] Jumaily M, Faraji F, Zhang D, Walker RJ, Ward GM. Basaloid squamous cell carcinoma of the larynx: a National Cancer Database analysis. Otolaryngol Head Neck Surg. 2019;160(3):519-526. Available from: https://doi.org/10.1177/0194599818816299.
[9] Vasudev P, Boutross-Tadross O, Radhi J. Basaloid squamous cell carcinoma: two case reports. Cases J. 2009;2:9351. Available from: https://doi.org/10.1186/1757-1626-2-9351.
[10] Ishida H, Fujishima F, Onodera Y, et al. Esophageal carcinosarcoma with basaloid squamous cell carcinoma: a case report and review of the literature. Tohoku J Exp Med. 2019;249(4):255-263. Available from: https://doi.org/10.1620/tjem.249.255.
[11] Ii R, Nakayama M, Tanaka S, Akutsu H, Tabuchi K. Successful treatment of basaloid squamous cell carcinoma of the nasal cavity with brain invasion. Cureus. 2023;15(2):e35293. Available from: https://doi.org/10.7759/cureus.35293.
[12] Shen W, Sakamoto N, Yang L. Cause-specific mortality prediction model for patients with basaloid squamous cell carcinomas of the head and neck: a competing risk analysis. J Cancer. 2018;9(3):482-488. Available from: https://doi.org/10.7150/jca.20274.
[13] Winters R, Naud S, Evans MF, Trotman W, Kasznica P. Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases. Head Neck Pathol. 2008;2(4):265-271. Available from: https://doi.org/10.1007/s12105-008-0089-7.
[14] Thariat J, Ahamad A, El-Naggar AK, et al. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck. Cancer. 2008;112(12):2698-2709. Available from: https://doi.org/10.1002/cncr.23486.
[15] Beer KT, Laissue J, Greiner RH, Aebersold DM. Carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Head Neck. 2001;23(9):758-763.
[16] Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2001;92(3):304-309.
[17] Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-720.
[18] Grizzo FC, Go DS. Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma. Oral Oncol. 2004;40(2):130-136.
[19] D’Souza G, Kreimer AR, Viscidi R, et al. Case report: basaloid squamous cell carcinoma – a rare and aggressive variant of squamous cell carcinoma: a case report and review of literature. Niger J Med Sci. 2018;17(1):9-13. Available from: https://doi.org/10.4103/njms.NJMS_16_18.
[20] Toe BP, Lond F, Ramli N, et al. Basaloid squamous cell carcinoma of the sinonasal tract with metastasis to the liver: a case report and literature review. Ear Nose Throat J. 2015;94(2):27-32. Available from: https://doi.org/10.1177/014556131509400216.
[21] Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567-578. Available from: https://doi.org/10.1056/NEJMoa053422.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jeeven Velayutham, Jeyasakthy Saniasiaya, Mohd Zulkiflee Bin Abu Bakar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
